Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.

Brevini, Teresa; Maes, Mailis; Webb, Gwilym J; John, Binu V; Fuchs, Claudia D; Buescher, Gustav; Wang, Lu; Griffiths, Chelsea; Brown, Marnie L; Scott, William E; Pereyra-Gerber, Pehuén; Gelson, William T H; Brown, Stephanie; Dillon, Scott; Muraro, Daniele; Sharp, Jo; Neary, Megan; Box, Helen; Tatham, Lee; Stewart, James; Curley, Paul; Pertinez, Henry; Forrest, Sally; Mlcochova, Petra; Varankar, Sagar S; Darvish-Damavandi, Mahnaz; Mulcahy, Victoria L; Kuc, Rhoda E; Williams, Thomas L; Heslop, James A; Rossetti, Davide; Tysoe, Olivia C; Galanakis, Vasileios; Vila-Gonzalez, Marta; Crozier, Thomas W M; Bargehr, Johannes; Sinha, Sanjay; Upponi, Sara S; Fear, Corrina; Swift, Lisa; Saeb-Parsy, Kourosh; Davies, Susan E; Wester, Axel; Hagström, Hannes; Melum, Espen; Clements, Darran; Humphreys, Peter; Herriott, Jo; Kijak, Edyta; Cox, Helen.

Nature ; 615(7950): 134-142, 2023 03.

Artigo em Inglês | MEDLINE | ID: mdl-36470304

2.

Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes.

Wester, Axel; Shang, Ying; Toresson Grip, Emilie; Matthews, Anthony A; Hagström, Hannes.

Gut ; 73(5): 835-843, 2024 Apr 05.

Artigo em Inglês | MEDLINE | ID: mdl-38253482

3.

Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis.

Nasr, Patrik; Wester, Axel; Ekstedt, Mattias; Strandberg, Rickard; Kechagias, Stergios; Shang, Ying; Widman, Linnea; Hagström, Hannes.

Clin Gastroenterol Hepatol ; 22(5): 1048-1057.e2, 2024 May.

Artigo em Inglês | MEDLINE | ID: mdl-38237695

4.

Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study.

Wester, Axel; Jepsen, Peter; Hagström, Hannes.

Liver Int ; 2024 Apr 23.

Artigo em Inglês | MEDLINE | ID: mdl-38651770

5.

Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients.

Hegmar, Hannes; Wester, Axel; Aleman, Soo; Backman, Jens; Degerman, Erik; Ekvall, Håkan; Lund, Katarina; Lundgren, Åsa; Nasr, Patrik; Shahnavaz, Afshin; Vessby, Johan; Westin, Johan; Önnerhag, Kristina; Hagström, Hannes.

Liver Int ; 2024 Apr 01.

Artigo em Inglês | MEDLINE | ID: mdl-38560775

6.

Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study.

Wester, Axel; Ndegwa, Nelson; Hagström, Hannes.

Clin Gastroenterol Hepatol ; 21(5): 1271-1280.e7, 2023 05.

Artigo em Inglês | MEDLINE | ID: mdl-35811047

7.

Three-fold Increased Risk of Death in Budd-Chiari Syndrome Compared to Matched Controls: A Population-based Cohort Study.

Åberg, Fredrik; Rajani, Rupesh; Wester, Axel; Widman, Linnea; Hagström, Hannes.

Clin Gastroenterol Hepatol ; 21(4): 995-1004.e9, 2023 04.

Artigo em Inglês | MEDLINE | ID: mdl-35569740

8.

Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients.

Hagström, Hannes; Shang, Ying; Tapper, Elliot B; Wester, Axel; Widman, Linnea.

Clin Gastroenterol Hepatol ; 21(13): 3336-3345.e2, 2023 12.

Artigo em Inglês | MEDLINE | ID: mdl-37192714

9.

Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study.

Ebrahimi, Fahim; Simon, Tracey G; Hagström, Hannes; Söderling, Jonas; Wester, Axel; Roelstraete, Bjorn; Ludvigsson, Jonas F.

Clin Gastroenterol Hepatol ; 21(13): 3346-3355.e19, 2023 12.

Artigo em Inglês | MEDLINE | ID: mdl-37245712

10.

Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population-based cohort study.

Schönau, Johanna; Wester, Axel; Schattenberg, Jörn M; Hagström, Hannes.

J Intern Med ; 294(2): 164-177, 2023 08.

Artigo em Inglês | MEDLINE | ID: mdl-36823685

11.

Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study.

Shang, Ying; Widman, Linnea; Ebrahimi, Fahim; Ludvigsson, Jonas F; Hagström, Hannes; Wester, Axel.

Liver Int ; 43(10): 2142-2152, 2023 10.

Artigo em Inglês | MEDLINE | ID: mdl-37475642

12.

Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients.

Lissing, Mattias; Wester, Axel; Vassiliou, Daphne; Floderus, Ylva; Harper, Pauline; Sardh, Eliane; Wahlin, Staffan.

J Inherit Metab Dis ; 46(6): 1186-1194, 2023 11.

Artigo em Inglês | MEDLINE | ID: mdl-37650859

13.

Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients.

Åström, Hanne; Wester, Axel; Hagström, Hannes.

Scand J Gastroenterol ; 58(8): 931-936, 2023.

Artigo em Inglês | MEDLINE | ID: mdl-36890670

14.

Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study.

Wester, Axel; Hagström, Hannes.

J Intern Med ; 292(3): 492-500, 2022 09.

Artigo em Inglês | MEDLINE | ID: mdl-35373876

15.

Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up.

Holmer, Magnus; Ekstedt, Mattias; Nasr, Patrik; Zenlander, Robin; Wester, Axel; Tavaglione, Federica; Romeo, Stefano; Kechagias, Stergios; Stål, Per; Hagström, Hannes.

Liver Int ; 42(12): 2769-2780, 2022 12.

Artigo em Inglês | MEDLINE | ID: mdl-36166317

16.

Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER).

Hagström, Hannes; Shang, Ying; Wester, Axel; Widman, Linnea.

Scand J Gastroenterol ; 57(8): 978-983, 2022 08.

Artigo em Inglês | MEDLINE | ID: mdl-35293282

17.

Reply.

Hagström, Hannes; Shang, Ying; Tapper, Elliot B; Wester, Axel; Widman, Linnea.

Clin Gastroenterol Hepatol ; 22(3): 670, 2024 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-37660766

18.

Reply.

Wester, Axel; Hagström, Hannes.

Clin Gastroenterol Hepatol ; 21(6): 1678, 2023 06.

Artigo em Inglês | MEDLINE | ID: mdl-36257510

19.

Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based Study.

Wester, Axel; Åberg, Fredrik; Rajani, Rupesh; Hagström, Hannes.

Clin Gastroenterol Hepatol ; 21(10): 2689-2691.e1, 2023 09.

Artigo em Inglês | MEDLINE | ID: mdl-36087708

20.

Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis.

Schönau, Johanna; Wester, Axel; Hagström, Hannes; Schattenberg, Jörn M.

J Intern Med ; 294(4): 537-538, 2023 10.

Artigo em Inglês | MEDLINE | ID: mdl-37276428

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2.

Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes.

Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis.

Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based study.

Liver stiffness predicts progression to liver-related events in patients with chronic liver disease - A cohort study of 14 414 patients.

Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort Study.

Three-fold Increased Risk of Death in Budd-Chiari Syndrome Compared to Matched Controls: A Population-based Cohort Study.

Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients.

Risk of Severe Infection in Patients With Biopsy-proven Nonalcoholic Fatty Liver Disease - A Population-based Cohort Study.

Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population-based cohort study.

Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study.

Porphyrin precursors and risk of primary liver cancer in acute intermittent porphyria: A case-control study of 188 patients.

Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patients.

Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study.

Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up.

Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER).

Reply.

Reply.

Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based Study.

Authors reply: Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis.